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 Abstract 
 Zinc metallopeptidases of bacterial pathogens are widely dis-
tributed virulence factors and represent promising pharma-
cological targets. In this work, we have characterized Zmp1, 
a zinc metallopeptidase identifi ed as a virulence factor of 
 Mycobacterium tuberculosis and belonging to the neprilysin 
(NEP; M13) family, whose X-ray structure has been recently 
solved. Interestingly, this enzyme shows an optimum activity 
toward a fl uorogenic substrate at moderately acidic pH values 
(i.e., 6.3), which corresponds to those reported for the Mtb 
phagosome where this enzyme should exert its pathological 
activity. Substrate specifi city of Zmp1 was investigated by 
screening a peptide library. Several sequences derived from 
biologically relevant proteins were identifi ed as possible 
substrates, including the neuropeptides bradykinin, neuro-
tensin, and neuropeptide FF. Further, subsequences of other 
small bioactive peptides were found among most frequently 
cleaved sites, e.g., apelin-13 and substance P. We determined 
the specifi c cleavage site within neuropeptides by mass spec-
trometry, observing that hydrophobic amino acids, mainly 
phenylalanine and isoleucine, are overrepresented at position 
P1 ′ . In addition, the enzymatic mechanism of Zmp1 toward 
these neuropeptides has been characterized, displaying some 
differences with respect to the synthetic fl uorogenic substrate 
and indicating that the enzyme adapts its enzymatic action to 
different substrates. 
 Keywords:  drug development;  enzyme kinetics;  metallo-
peptidase;  Mycobacterium tuberculosis ;  peptide hormones; 
 phagosome maturation. 
 Introduction 
 Tuberculosis (TB), the major bacterial cause of mortality 
around the world, kills about 2 million people annually, and 
approximately one third of the world ’ s population is asymp-
tomatically infected with  Mycobacterium tuberculosis (Mtb), 
the main causative agent of the disease (WHO Fact sheet; 
http://www.who.int/mediacentre/factsheets/fs104/en/index.
html). The prolonged coevolution of Mtb with its human 
hosts, and specifi cally with macrophages, has turned out in 
a peculiar survival strategy. Unlike other bacteria, which 
have developed different strategies, pathogenic Mtb has 
evolved to block lysosomal delivery (Nguyen and Pieters , 
2005 ; Warner and Mizrahi , 2007 ). Hence, the pathogenic Mtb 
strategy demands that it actively subverts normal cellular 
mechanisms to avoid being killed (Nguyen and Pieters , 2005 ; 
Masjedi et al. , 2006 ). 
 The Rv0198c gene of Mtb encodes for the zinc metallo-
peptidase 1 (Zmp1; 663 aa), which, although not required for 
mycobacterial growth  per se , turned out to be essential for 
survival inside host macrophages (Master et al. , 2008 ). An 
equivalent peptidase gene is also conserved in  Mycobacterium 
leprae (MLCL622.12c; 667 aa), the causative agent of lep-
rosy, whose genome exhibits massive gene decay (Cole et al. , 
2001 ). Master et al.  (2008) have described Zmp1 as a secreted 
virulence factor of Mtb, involved in phagosome maturation 
arrest. Zmp1 manipulates host immune defence by interfer-
ing with the activation of a multiprotein complex termed 
infl ammasome. Furthermore, Zmp1 deletion infl uences the 
presentation of mycobacterial antigens, thus increasing the 
immunogenicity of vaccine strain  Mycobacterium bovis 
Bacille Calmette-Guerin (Johansen et al. , 2011 ). The impor-
tant role of Zmp1 in Mtb pathogenicity has been recently con-
fi rmed in a mouse model (Muttucumaru et al. , 2011 ), although 
some questioning about the mechanism remains open. 
 Zmp1 belongs phylogenetically to the MEROPS peptidase 
family M13 and displays the conserved HExxH active site aThese authors contributed equally to this work.
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motif common to all Zn 2 +  metallopeptidases. The targets of 
M13 members usually are bioactive peptides with a key func-
tion in the regulation of cardiovascular, nervous, and immune 
systems (Turner et al. , 2001 ). Zmp1 shares particularly pri-
mary sequence similarity (48 % ) with human neprilysin (NEP; 
749 aa), an extracellular peptidase that preferentially hydro-
lyzes extracellular oligopeptides ( < 5 kDa) on the amino side 
of hydrophobic residues (also including amyloid  β peptides 
implicated in Alzheimer disease) (Carson and Turner , 2002 ; 
Madani et al. , 2006 ). We recently solved the crystal structure 
of Zmp1, and our investigation demonstrated that Zmp1 and 
NEP are also structurally conserved (Ferraris et al. , 2011 ). A 
major aspect concerns the active site of Zmp1, which is acces-
sible only through a narrow channel, rendering diffi cult the 
interaction with large macromolecular substrates; therefore, 
the enzyme seems more tailored to process peptides. Here we 
report the characterization of the proteolytic activity of Zmp1 
metallopeptidase, describing its substrate preferences using a 
microarray-based peptide library and analyzing its cleavage 
specifi city by mass spectrometry (MS). In addition, we have 
investigated the pH effect on Zmp1 catalysis, revealing an 
optimum activity at moderately acidic pH values, which are 
substrate-dependent. 
 Results 
 Zmp1 activity depends on Zn 2 +  binding 
 Mtb Zmp1 was cloned into a prokaryotic expression vec-
tor carrying a His 6 modifi cation at its N-terminus and heme 
agglutinin (HA) tag at its C-terminus for purifi cation and 
detection. In addition, glutathione- S -transferase (GST)-
Zmp1-His/HA tagged protein was cloned. Both proteins were 
expressed to high levels in  Escherichia coli and purifi ed in a 
two-step approach using HisTrap column and ion exchange/
GST-sepharose beads. Purity was  > 95 % according to a single 
band at the expected molecular weight in the SDS-PAGE 
(Figure  1 A). Two mutants in the HExxH signature motif were 
produced by site-directed mutagenesis, namely H493A (His 493 
was altered to Ala) and E494A mutant (Glu 494 was altered to 
Ala). Both mutated proteins were produced in a stable and 
soluble form and were purifi ed to a high degree (Figure 1A 
and B). 
 To complement the crystallography data with the study of 
the protein in solution, circular dichroism (CD) spectroscopy 
was applied to Zmp1. In accord with the crystal structure 
(Ferraris et al. , 2011 ), all purifi ed forms of Zmp1 [i.e., wild 
type (wt) and the mutant] are properly folded, displaying iden-
tical CD spectra (Figure 1C). As predicted from the primary 
amino acid sequence and in agreement with the crystal struc-
ture (Ferraris et al. , 2011 ), the secondary structure of Zmp1 
displays over 70 % of an  α -helix structure, as estimated from 
the molar ellipticity at 222 nm (Morrow et al. , 2000 ). Salts, 
such as CaCl 2 and NaCl, do not alter the thermal stability of 
Zmp1 helical folding (data not shown). 
 Zmp1 is able to cleave a synthetic fl uorogenic substrate 
(see Materials and methods), which is specifi c for a family 
of zinc endoproteinases, called matrix metalloproteinases 
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 Figure 1  Purifi cation of Zmp1 and its structure in solution. 
 (A) Coomassie stain of 12.5 % SDS-gel and (B) Western blotting of 
Zmp1 variants. Lanes: 1, Zmp1 wt; 2, GST-Zmp1; 3, GST-Zmp1 
E494A; 4, GST-Zmp1 H493A. Zmp1 shows the predicted molecular 
mass of 72 kDa. The three GST-tagged variants have a molecular 
mass of approximately 100 kDa due to the fusion with a 26-kDa 
GST tag. (C) CD spectra of Zmp1. Dashed line corresponds to the 
CD spectrum of the Zmp1 wt; continuous line refers to the inactive 
E494A Zmp1. 
(MMPs), sharing the catalytic motif (i.e., HExxH) with the 
M13 family. GST-Zmp1 wt cleaved the fl uorogenic substrate 
with high effi ciency and, as expected, mutating the catalytic 
motif almost abolished the proteolytic activity. Likewise, 
EDTA and the Zn 2 +  chelator 1,10-phenanthroline reduced 
Zmp1 activity (see Table  1 ). Zmp1 activity was also strongly 
inhibited by the potent M13 metallopeptidase inhibitor phos-
phoramidon with a  K I = 3.5( ± 0.5) × 10 -8  m (Ferraris et al. , 
2011 ). The enzyme does not undergo autoproteolysis during 
 Table 1  Effect of peptidase inhibitors on the activity of Zmp1. 
Inhibitor Concentration 
(m m )
Zmp1 activity 
( % of control)
Phosphoramidon 0.1   5.1 ± 1.2
1,10-Phenanthroline 0.1   7.8 ± 3.2
EDTA 1 46.4 ± 8.3
 Zmp1 (10 n m ) was preincubated with inhibitor for 10 or 60 min (in 
case of EDTA) at room temperature. Activity toward the synthetic 
fl uorogenic substrate was measured after 5 min at 37 ° C ( ± SD). 
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 Figure 2  pH dependence of catalytic parameters for Zmp1 at 37 ° C against a synthetic fl uorogenic substrate. 
 (A) pH dependence of  k 
cat / K m . Continuous line represents the non-linear least squares fi tting of data using Eq. (4a) with parameters reported in 
Table 2. (B) pH dependence of  k 
cat . Continuous line represents the nonlinear least squares fi tting of data using Eq. (4b) with parameters reported 
in Table 2. (C) pH dependence of  K 
m
 . Continuous line represents the non-linear least squares fi tting of data using Eq. (4c) with parameters 
reported in Table 2. (D) Ilomastat concentration dependence of substrate affi nity constant  K 
m
 for Zmp1 at 37 ° C. Values of  obs K 
m
 have been 
obtained by Lineweaver-Burk plot of omni-MMPs fl uorogenic peptide cleavage in the presence of Zmp1 (0.4 n m ) in absence and presence of 
different Ilomastat concentrations (namely 5, 10, 15, 30, and 60  μ m ). The continuous line is the nonlinear least squares fi tting of data according 
to Eq. (5), from which a value of  0 K 
m
 = 4.4( ± 0.6) × 10 -6  m and a value of  K I = 5.9( ± 0.7) × 10 -5 are obtained. 
the activity assay, as proven by the Selwyn test (Selwyn , 
1965 ) (see Figure  S1 ). 
 pH dependence of Zmp1 proteolytic activity 
 The pH dependence of Zmp1 activity was fi rst measured using 
a synthetic fl uorogenic substrate. From the analysis of the 
dependence on the substrate concentration at each pH value 
according to Eqs. (2) and (3) (see Materials and methods), 
we have obtained the catalytic parameters (i.e.,  k 
cat / K m ,  k cat , 
and  K 
m
 ) at each investigated pH. Their pH dependence is 
reported in Figure  2 A – C for  k 
cat / K m (A),  k cat (B), and  K m (panel 
C). obtaining the p K 
a
 values reported in Table  2 . Although 
the nonlinear least squares fi tting of the pH dependence of 
individual parameters might have been carried out with only 
two protonatable groups, the global fi tting of the pH depen-
dence of all three catalytic parameters demanded three proto-
natable groups [i.e., n = 3 in Eqs. (4a) – (4c); see Materials and 
methods]. Evidently, the overall enzymatic activity of Zmp1 
(corresponding to  k 
cat / K m ) is highest at pH 6.3 (Figure 2A), 
a pH value quite low compared with other metallopeptidases 
(Fasciglione et al. , 2000 ). Further, the pH dependence of  K 
m
 
(Figure 2C) indeed suggests that the substrate affi nity tends to 
increase at pH lower than 7.5, as  K 
m
 decreases. An interest-
ing pattern is observed for the pH dependence of  k 
cat (Figure 
2B), where it appears evident that at least two groups with 
markedly different p K 
a
 values are modulating this parameter. 
In particular, it is worth underlining that the two-protonated 
species appears to be the most active form of Zmp1 and that 
this enhanced activity is connected to a residue characterized 
by a p K 
a
 = 6.73 ± 0.17 in the free enzyme, which then shifts to 
p K 
a
 = 7.72 ± 0.16 in the substrate-bound form (Table 2). As a 
consequence, the pH-dependent profi le of  k 
cat appears some-
what displaced toward higher pH values. 
 Zmp1 inhibition by Ilomastat 
 The inhibition constant by Ilomastat has been determined 
for Zmp1, exploiting the inhibitor concentration depen-
dence of the substrate affi nity (Figure 2D). Application of 
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 Table 2  Catalytic parameters for the different protonated species of 
Zmp1 toward the synthetic fl uorogenic substrate and p K 
a
 values for 
the protonating groups in the free enzyme (p K U ) and of the substrate-
bound enzyme (p K L ). 
 k 
cat / K m ( m -1 s -1 )  k cat (s -1 )  K m ( m )
0-Protonated 5.0 ( ± 0.7) × 10 3 0.012 ± 0.004 2.4 ( ± 0.4) × 10 -6 
1-Protonated 7.1 ( ± 0.9) × 10 3 0.131 ± 0.029 1.9 ( ± 0.3) × 10 -5 
2-Protonated 3.0 ( ± 0.5) × 10 4 0.065 ± 0.017 2.2 ( ± 0.5) × 10 -6 
3-Protonated 9.5 ( ± 1.6) × 10 2 0.008 ± 0.001 8.4 ( ± 1.6) × 10 -6 
p K U1 8.17 ± 0.16
p K U2 6.73 ± 0.17
p K U3 5.43 ± 0.19
p K L1 7.22 ± 0.18
p K L2 7.72 ± 0.17
p K L3 5.69 ± 0.18
Eq. (5) (see Materials and methods) allows to determine the 
 K I [ = 5.9( ± 0.7) × 10 -5  m ], which is about 10 5 -fold higher than 
that observed for matrix metallopeptidases (Galardy et al. , 
1994 ), refl ecting a very low affi nity of Ilomastat for Zmp1. 
This result indicates that Ilomastat is a very weak inhibitor for 
Zmp1, confi rming the known difference between gluzincins 
and metzincins, as indeed it turns out to be evident also from 
the crystallographic structure, where the catalytic site results 
different from that of other metallopeptidases  (Ferraris et al. , 
2011 ). 
 Zmp1 hydrolyzes a variety of bioactive peptides 
 To possibly identify the native substrate(s) of Zmp1, we car-
ried out an extensive screening of a microarray-based pep-
tide library. The library consists of 1989 octameric peptides 
derived from annotated cleavage sites of peptidases or ran-
dom sequences and 1536 pentadecameric random peptide 
sequences. Peptides are C-terminally tagged with a phospho-
rylated tyrosine for detection. Peptide cleavage was quanti-
fi ed by incubation with antiphosphotyrosine and fl uorescent 
secondary antibody labeling and following fl uorescence 
measurement. Fluorescence intensity of 51 out of 3525 pep-
tide spots was decreased by more than 90 % as compared 
with the bovine serum albumin control. The 51 substrates 
were categorized into three groups (Table  S1 ): (1) neuropep-
tides/substrates of NEP or endothelin-converting enzyme 1 
(ECE-1); (2) coagulation factors; (3) others. Interestingly, 
only short peptides (octameric) were represented among the 
top substrates. The relative frequency of each amino acid in 
the effi ciently cleaved peptides was calculated by dividing 
the number of times this specifi c amino acid is represented 
in the screened substrates over the number of times that the 
amino acid is represented in the whole peptide microarray. 
This statistical analysis provides information about the amino 
acid preferences in the substrates, although it does not allow 
prediction of actual cleavage sites. The most common motif 
among the top substrates was the sequence SPFR, which is 
present in the carboxy terminal part of the peptide hormone 
bradykinin. In particular, the statistical analysis showed an 
overrepresentation of arginine, phenylalanine, isoleucine, 
leucine, and valine in the top substrate sequences, whereas 
acidic amino acids such as aspartic or glutamic acid were 
underrepresented, and no cysteine or tryptophan were present 
in any of the 51 top substrates. 
 Zmp1 cleavage motif 
 Several cleavage motifs can be described from the MALDI-
TOF cleavage analysis of the investigated peptides (Figure 
 3 A). The phenylalanine was the most represented residue 
at P1 ′ position (Figure 3B), although isoleucine and leucine 
were also abundant at this position. Proline was frequently 
found in the P3 site, although other positions near the cleav-
age site showed little preference. We conclude that PxxF is a 
preferred cleavage motif of Zmp1 and phenylalanine occu-
pies P1 ′ position. 
 Identifi cation of substrate cleavage sites 
 First, we characterized the cleavage pattern of several neuro-
peptides identifi ed in the peptide array (i.e., bradykinin, ape-
lin-13, neurotensin, neuropeptide FF), including some NEP or 
ECE-1 substrates [i.e., substance P, dynorphin A (1 – 13), and 
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 Figure 3  Hydrolysis of hormone peptides by Zmp1. 
 (A) Cleavage sites detected in the Zmp1 hydrolyzed fl uorogenic pep-
tides: 1, angiotensin I; 2, neurotensin; 3, apelin-13; 4, dynorphin A 
(1 – 13). Neuropeptide FF cleavage pattern was not studied because of 
poor detection signals in the MALDI-TOF analysis. (B) Amino acid 
preferences at various position of Zmp1 substrates calculated on the 
basis of the cleavage pattern of the studied hormone peptides. Size of 
amino acid letter is proportional to their occurrence in the recogni-
tion/cleavage motif. Cleavage site (marked with red arrow) is loca-
lized between position P1 and P1 ′ (drawn using Weblogo 3.0). 
Enzymatic activity of Zmp1 from  M. tuberculosis  635
angiotensin I], and the reaction by-products were analyzed by 
MALDI-TOF; to guarantee specifi c cleavage, a high substrate/
enzyme ratio was used (1000:1). Two cleavage sites were 
detected in bradykinin (Figure  4 A), i.e., between Pro 7 -Phe 8 and 
Gly 4 -Phe 5 , confi rming the results obtained with the extended 
bradykinin, which is generated by the proteolytic cleavage of 
the precursor kininogen-1 by the enzyme kallikrein (Kaplan 
et al. , 2002 ). As a matter of fact, in rat, mouse, bovine, and 
human, the SPFR motif of kininogen-1 is conserved, but it is 
followed by a different carboxy terminal amino acid. Four zinc 
metallopeptidases are mainly responsible for the metabolism 
of bradykinin, namely angiotensin-converting enzyme (ACE), 
NEP, aminopeptidase P, and carboxypeptidases M and N 
(Moreau et al. , 2005 ). Both cleavages resulted in two respective 
fragments that were detected by MALDI-TOF (Figure 4B and 
C). We determined three cleavage sites in substance P: between 
Gln 6 -Phe 7 , Phe 7 -Phe 8 , and Gly 9 -Leu 10 (Figure 4D; Figure S2). 
Interestingly, all the cleavage sites of bradykinin and substance 
P have a hydrophobic amino acid in the P1 ′ site, mainly phe-
nylalanine, which is typical of NEP, ECE-1, and thermolysin; 
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 Figure 4  Cleavage sites of bradykinin and substance P by Zmp1. 
 (A) Determination of fragments of the  ‘ extended ’ bradykinin (bradykinin sequence in bold) by Zmp1 through LC-MS analysis. Three different 
cleavage sites were detected in bradykinin. Primary site of hydrolysis is shown by the arrow with one asterisk, and secondary sites are shown 
by the arrows with two asterisks. (B) MALDI-TOF spectrum of fl uorogenic bradykinin. (C) MALDI-TOF spectrum of Zmp1 hydrolyzed fl uo-
rogenic bradykinin. The C-terminal fragments showed an additional mass peak ( Δ 16 Da), due to a loss of oxygen (as described recently for 
nitro-phenyl-derivatives; see Petersson et al. , 2001 ). (D) Cleavage sites of fl uorogenic substance P by Zmp1. The arrows above the amino acid 
sequence of substance P indicate the cleavage sites. 
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further, this observation is in agreement with the overrepre-
sentation of this amino acid in the top substrates as compared 
with the total peptide library. Specifi c sites of cleavage within 
the other neuropeptides, such as angiotensin I (Figure S3), 
apelin-13 (Figure S4), dynorphin A (1 – 13) (Figure S5), and 
neurotensin (Figure S6) are summarized in Figure 3A. 
 Further, we synthesized a peptide fragment of mouse kini-
nogen with the sequence RPPGFSPFRSVTV to map the 
cleavage site (bradykinin sequence in bold). The peptide was 
incubated with Zmp1 for 60 and 120 min, respectively, and 
products were analyzed by LC-MS. Cleavage sites were deter-
mined by calculating the molecular weight of putative prod-
ucts (data not shown). Primary cleavage occurred between 
Pro 7 and Phe 8 (Figure 4A, arrow with one star). This cleavage 
site lies within the bradykinin sequence and results in the inac-
tivation of bradykinin rather than releasing bradykinin from its 
precursor. This peptide bond is also targeted by ACE, the main 
enzyme responsible for the metabolism of bradykinin (Blais 
et al. , 2000 ). Further cleavages were detected after longer 
incubation of the peptide with Zmp1, e.g., between Gly 4 -Phe 5 
and Ser 10 -Val 11 (Figure 4A, arrows with two stars). 
 Kinetic analysis of neuropeptides cleavage 
 Zmp1 hydrolysis of the neuropeptides was further studied 
by the determination of kinetic constants  K 
m
 and  k 
cat . As the 
kinetic course of peptide cleavage by Zmp1 was affected by 
product inhibition and/or cleavage of multiple peptide bonds, 
initial velocities were exploited for calculating the kinetic 
parameters of the most susceptible peptide bond within a given 
peptide. Results are summarized in Table  3 as best fi t values 
with associated standard errors from nonlinear regression 
of the Michaelis-Menten equation fi tted to data. The kinetic 
parameters for angiotensin I and neurotensin could not be cal-
culated because even the initial velocity was strongly affected 
by the concurrent multiple cleavage and multiple product 
inhibition. Figure  5 A shows, as an example, the double recip-
rocal Lineweaver-Burk plot for substance P, apelin-13, and 
bradykinin; it clearly emerges that substance P and apelin-13 
are the best substrates among those investigated. 
 pH dependence of substance P and apelin-13 
hydrolysis 
 In several studies, ECE-1 was found to cleave neuropep-
tides inside acidifi ed endosomes (i.e., at pH ≈ 5.5) (Padilla et 
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 Figure 5  Kinetic analysis of Zmp1 hydrolysis of apelin-13, sub-
stance P, and bradykinin. 
 (A) Double-reciprocal Lineweaver-Burk plot of the enzymatic pro-
cessing by Zmp1 of apelin-13 (o), substance P (x), and bradykinin (*) 
at 37 ° C and pH 7.3. Solid lines represent the non-linear least squares 
fi tting of data according to Eq. (2). (B) pH dependence of the rate of 
cleavage ( k 
cat / K m ) of apelin-13 (o) and substance P (x) by Zmp1 at 
37 ° C. Continuous lines represent the nonlinear least squares fi tting 
of data according to Eq. (4a). 
 Table 3  Kinetic parameters for the cleavage of the most susceptible 
peptide bond in fi ve peptides substrates of Zmp1. 
Substrate  k 
cat (s -1 )  K m ( μ m )  k cat / K m ( m -1 s -1 )
Apelin 1.54 ± 0.08 1.09 ± 0.23 1.41 ± 0.31 × 10 6 
Substance P 4.78 ± 0.71 3.92 ± 1.37 1.22 ± 0.46 × 10 6 
Bradykinin 2.76 ± 0.42 7.99 ± 1.45 3.46 ± 0.67 × 10 5 
Dynorphin A 2.25 ± 0.22 5.72 ± 1.22 3.93 ± 0.92 × 10 5 
Neuropeptide FF 1.07 ± 0.16 3.02 ± 1.15 3.56 ± 1.45 × 10 5 
 Values of  k 
cat and  K m , determined by non-linear regression from a 
fi t of the Michaelis-Menten equation to primary data, are shown 
together with the standard errors from regression. 
al. , 2007 ; Roosterman et al. , 2007 ). We determined the pH 
dependence of Zmp1 activity for additional substrates, i.e., 
apelin-13 and substance P to see the pH preference for these 
substrates. Zmp1 cleaved the two neuropeptides preferentially 
in the pH range between 6.5 and 8.0 rather than at more acidic 
pH values, as observed for the fl uorogenic substrate (Figure 2 
for the pH profi le of the fl uorogenic substrate, Figure 5B for 
that of substance P and apelin-13). Data obtained from the 
pH-dependence of apelin-13 and substance P degradation by 
Zmp1 are reported in Table  4 . 
 Screening for macromolecular substrates (longer than 
40 amino acids) 
 Using an  in vitro proteolysis assay we have investigated the 
enzymatic action of Zmp1 on four of the substrates reported 
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 Table 4  Values of  k 
cat / K m ( m -1 s -1 ) for the different protonated species 
of Zmp1 toward apelin-13 and substance P and p K 
a
 for the protonating 
groups in the free enzyme (p K U ). 
Apelin-13 Substance P
0-Protonated 9.0 ( ± 1.6) × 10 5 8.8 ( ± 1.6) × 10 5 
1-Protonated 1.7 ( ± 0.4) × 10 6 3.1 ( ± 0.7) × 10 6 
2-Protonated 6.5 ( ± 1.1) × 10 5 1.6 ( ± 0.4) × 10 5 
3-Protonated 1.0 ( ± 0.8) × 10 4 1.0 ( ± 0.7) × 10 5 
p K U1 8.17 ± 0.16
p K U2 6.73 ± 0.17
p K U3 5.43 ± 0.19
on the top substrates list of the peptide array:  β -amyloid, 
 α -fi brinogen chain, insulin, and denatured collagen. We have 
further tested Zmp1 proteolytic activity on caspase 1, the 
IL-1 β activating enzyme. However, even prolonged exposi-
tion to Zmp1 (up to 24 h) did not lead to any appreciable 
cleavage of these potential substrates (data not shown). In 
contrast, a control incubation with trypsin led to complete 
digestion of the  α -,  β -, and  γ -fi brinogen chains already after 
1 h of incubation. 
 Discussion 
 Zinc metallopeptidases represent promising pharmacologi-
cal targets and potential candidates for vaccine development 
(Miyoshi and Shinoda , 2000 ; Aureli et al., 2008; Lopez -Otin 
and Bond, 2008 ; Baillie et al. , 2010 ). We have investigated 
the wt and the inactive mutants (H493A and E494A) of the 
metallopeptidase Zmp1, which is an important virulence fac-
tor of Mtb (Master et al. , 2008 ). 
 Zmp1 belongs to the M13 family (MEROPS database: 
http://merops.sanger.ac.uk/), such as NEP and ECE-1, whose 
enzymatic action is restricted to peptides with a strong prefer-
ence for cleaving the amino terminal bond of hydrophobic 
residues (Bland et al. , 2008 ). This preference for peptides is 
also confi rmed by the recently solved X-ray crystallographic 
structure of Zmp1, which reveals that the active site is located 
at the bottom of a hydrophobic channel, likely impairing the 
access of large macromolecular substrates in the proximity of 
the reaction centre (Ferraris et al. , 2011 ). 
 To better characterize the specifi city of Zmp1 a peptide 
microarray library was used (including octameric and pen-
tadecameric peptides); in particular, octameric peptides were 
enzymatically cleaved with the highest effi ciency. Further, 
a statistical analysis over the whole peptide array indicate a 
marked tendency of Zmp1 to cleave bonds where hydropho-
bic amino acids are located at the P1 ′ position, similarly to 
NEP and ECE-1. In addition, as shown by the  in vitro clea-
vage assay, sequences identifi ed by the peptide array could 
not be cleaved when they were fl anked by the whole protein 
sequences in a context of a structurally complex molecule 
(e.g., fi brinogen,  β -amyloid). 
 Among the hits screened, several neuropeptides have been 
identifi ed [i.e., substance P, neurotensin, bradykinin, apelin-13, 
angiotensin I, neuropeptide FF, and dynorphin A (1 – 13)]. With 
respect to these, it is interesting to remark that a member of M13 
family (ECE-1) localizes into the luminal side of endosomal 
membrane where it degrades interna lized neuropeptides (e.g., 
substance P, apelin-13) (El Messari et al. , 2004 ; Roosterman et 
al. , 2007 ; Cottrell et al. , 2009 ), suggesting their possible biolo-
gical relevance as substrates of this type of enzymes. As a mat-
ter of fact, besides the classical involvement of neuropeptides 
in neurotransmission and vasal smooth muscle cells constric-
tion, at least for some of them, a novel role in the modulation 
of immune responses has been envisaged (Skidgel et al. , 1984 ; 
Johnson et al. , 1999 ; Marriott and Bost , 2001 ; Yaraee et al. , 
2007 ), affecting proinfl ammatory cytokine and chemokine 
activation (in the case of apelin-13) and macrophage activation 
(in the case of the substance P) in the early phases of immune 
responses to  Salmonella infection (Kincy -Cain and Bost, 1996 ; 
 O ’ Connor et al., 2004 ; Leeper et al. , 2009 ). 
 A comparison between the degradation profi le of these 
substrates by Zmp1, NEP, and ECE-1 highlights overlapping 
specifi cities in terms of cleavage sites (i.e., for bradykinin, 
substance P, and dynorphin A) with minor differences (i.e., 
secondary cleavage sites in angiotensin I and neurotensin) 
(Matsas et al. , 1984 ; Johnson et al. , 1999 ). However, a sig-
nifi cant quantitative difference in terms of catalytic effi ciency 
with respect to ECE-1 is observed with  k 
cat / K m ratios, which in 
Zmp1 are 100- and 5-fold higher for substance P and brady-
kinin, respectively (Johnson et al. , 1999 ). On the whole, ape-
lin-13 turns out to be an excellent substrate for Zmp1, being 
effi ciently cleaved with the highest specifi city constant (i.e., 
 k 
cat / K m ) among all tested peptides, a feature mostly related to 
the binding specifi city rather than the cleavage effi ciency. 
 Although we cannot state at this stage whether these neuro-
peptides represent the Zmp1 substrate  in vivo , pH scanning of 
Zmp1 proteolytic activity toward all investigated peptides indi-
cates that Zmp1 can modulate its activity through the dynami-
cal pH changes that occur in the maturating phagosome. In 
this respect, it is noteworthy that degradation of neuropeptides 
by ECE-1 in endosomes under acidic conditions (i.e., pH 5.5) 
is documented (Fahnoe et al., 2000) and it is associated to 
intracellular signaling and receptor turnover (El Messari et al. , 
2004 ; Roostermann et al., 2007; Cottrell et al. , 2009 ); analo-
gously, we found that Zmp1 optimum activity toward the syn-
thetic substrate is at pH 6.3 (Figure 2A), a value corresponding 
to that of the early endosome (Pethe et al. , 2004 ). Therefore, 
it might be speculated that, similarly to ECE-1, Zmp1 oper-
ates within the phagosome, arresting its maturation (Master 
et al. , 2008 ; Johansen et al. , 2011 ). As a matter of fact, at the 
acid pH of the maturating phagosome (i.e., pH 6.3), the sub-
strate affi nity of Zmp1 is fairly high (i.e., 2  μ m ), suggesting a 
conformation of the active site particularly suitable to interact 
with substrates under quite acidic pH conditions. In the case 
of neuropeptides, such as apelin-13 and substance P, the opti-
mum pH is somewhat higher than that observed for the syn-
thetic substrate, although p K 
a
 values for the pH dependence of 
 k 
cat / K m are fully comparable. This strongly supports the idea 
that these p K 
a
 values refer only to the protonation of Zmp1 
residues with no contribution from residues of the substrate(s). 
Therefore, as the whole enzymatic mechanism of Zmp1 seems 
to be modulated by the protonation of three classes of residues 
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(characterized by p K 
a1 , p K a2 , and p K a3 , respectively), the dif-
ferent pH profi les between these substrates can be simply 
explained by the involvement of different protonated species 
(the 2-protonated for the synthetic substrate and the 1-proto-
nated for neuropeptides). This feature is clearly refl ecting a 
relevant difference between the two classes of substrates in 
their ionic interactions with the enzyme. 
 These investigations demonstrate the importance of Zmp1 
for mycobacteria host interaction and highlight its potential 
as a pharmacological target. Two major conclusions can be 
drawn: Zmp1 preferentially cleaves small peptides, among 
which neuropeptides appear particularly interesting; Zmp1 
adapts its activity to different microenvironmental conditions. 
The present biochemical characterization of the enzymatic 
properties of Zmp1 can be merged with the structural infor-
mation on Zmp1 (Ferraris et al. , 2011 ), allowing a structural-
functional correlation, which will be of the utmost importance 
for a rational drug design. 
 Materials and methods 
 Molecular cloning and protein expression 
 Mtb Zmp1 gene was subcloned into pET100/D-TOPO  ®  vector 
(Invitrogen) using a PCR-amplifi ed product from pMV361-Zmp1 
vector, carrying Zmp1 gene, as previously reported (Master et al. , 
2008 ). 
 For all constructs, 1-L overnight culture of  E. coli BL21 
(Invitrogen) in L-broth medium (induced at OD 600 = 0.8 with 0.5 m m 
IPTG and grown at 18 ° C) was centrifuged at 5000 g for 20 min, 
followed by washing with PBS and additional centrifugation at 
5000 g for 20 min. Cells were then lysed by three French press cy-
cles (Thermo Electron) at 1.4 × 10 8 Pa in the presence of peptidase 
inhibitors, followed by ultracentrifugation at 30 000 g for 60 min. 
Supernatants were loaded on HisTrap ™ HP column (GE Healthcare) 
equilibrated with buffer containing 20 m m NaH 2 PO 4 , pH 7.4, 0.5  m 
NaCl. Proteins were eluted with a concentration gradient of imida-
zole. Both Zmp1 and GST-Zmp1 were eluted at 250 m m imidazole 
(protein concentration was 0.5 – 1 mg/ml). After overnight dialysis 
against PBS, Zmp1 wt was further purifi ed by ion exchange using a 
Q Column (GE Healthcare). GST-Zmp1 purifi cation was performed 
using glutathione-sepharose beads (Glutathione Sepharose 4B; GE 
Healthcare). Proteins were dialyzed against PBS, and fi nally, glycer-
ol at a fi nal concentration of 10 % was added to store them in aliquots 
at -20 ° C. Proteins were analyzed by 12.5 % SDS-gel and subsequent 
Coomassie stain or Western blot against HA. All chemicals used 
were from Acros, Applichem, Fluka or Sigma-Aldrich. For detection 
of  recombinant Zmp1 the following antibodies are used: mouse anti-
HA (Roche) and goat anti-mouse-HRP (Molecular Probes). 
 CD experiments 
 CD spectra for the validation of the correct folding of the protein 
were recorded on a Jasco J-710 spectropolarimeter equipped with 
a thermostated cell holder and connected to a data station for signal 
averaging and processing. All spectra were averages of four scans 
and were recorded using quartz cells of 2-mm path length. Zmp1 
was dissolved in CD buffer (20 m m Tris-HCl, 1 m m CaCl 2 , 100 m m 
NaCl) at about 2  μ m concentration. The  α -helix content of Zmp1 was 
calculated from the molar ellipticity of circular dichroic spectrum at 
222 nm according to the following equation 
 %  α -helix = (-[ θ ] 222 nm + 3000)/39 000 (1) 
 where [ θ ] 222 nm is the molar ellipticity at 222 nm, as previously 
described (Morrow et al. , 2000 ). 
 Kinetic analysis and pH dependence of Zmp1 catalysis 
 Internally quenched fl uorogenic substrates with 7-methoxycoumarin 
(MCA) as fl uorophore and 2,4-dinitrophenol (DNP) as quencher 
were either a synthetic fl uorogenic substrate, displaying the follow-
ing sequence: 
 [(MCA-yl)acetyl]-Pro-Leu-Gly-Leu-DNP[ N -3-(2,4-dinitrophenyl)-
 l -2,3-diaminopropionyl]-Ala-Arg-NH 2 ) 
 or neuropeptides from EMC microcollections (T ü bingen, Germany). 
Neurotensin was synthesized with glutamine as N-terminal amino acid 
instead of pyroglutamic acid for ease of synthesis. The substrate peptides 
were prepared as stock solutions in 100 % dimethyl sulfoxide (DMSO) 
at a fi nal concentration of 1.0 m m and further diluted into the univer-
sal buffer (25 m m bis-Tris-HCl, 25 m m Tris-HCl, 100 m m NaCl, and 
10 m m CaCl 2 prepared at 25 ° C) to maintain an unaltered composition 
at different pH values over the range investigated, keeping the DMSO 
concentration constant at 1 % (v/v) for all dilutions. Substrate hydrolysis 
was measured fl uorometrically with an Eclypse fl uorimeter (Varian) or 
with a Flx800 spectrofl uorometer (BIOTEK) equipped with KC Junior 
Software (BIOTEK) ( λ 
exc
 = 327 nm,  λ 
em
 = 393 nm); reactions were start-
ed by adding Zmp1 (at a fi nal concentration of 10 n m ) to a solu tion con-
taining different substrates concentrations, spanning between 0.3 μ m 
and 5  μ m . For the pH dependence, Zmp1 was incubated in the universal 
buffer between pH 5.2 and 9.5 for 5 min at 37 ° C, then substrate was 
added, and fl uorescence signal was followed. Background fl uorescence 
of all buffers was similar. The initial velocities were measured at 37 ° C 
within a time interval during which the rate was constant and <10 % of 
the substrate has been degraded. It ensured a steady-state condition, and 
it was a prerequisite for the subsequent analysis step, which was based 
on the observation of an inverse linear correlation between velocity and 
substrate concentration according to Lineweaver-Burk equation [Eq. 
(2)] and Eadie-Hofstee linear regression [Eq. (3)] 
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 where  E 0 is the total enzyme concentration,  v is the actual rate 
(expressed as mol/s),  K 
m
 is the Michaelis-Menten equilibrium con-
stant (expressed as mol),  k 
cat is the rate-limiting step kinetic constant 
(expressed as s -1 ), [ S ] is the substrate concentration, and  V MAX is the 
ratio between  E 0 and  v . Linear regression plots were constructed 
from the velocity data, and the catalytic parameters  k 
cat and  K m were 
extracted. The pH dependence of the catalytic parameters has been 
fi tted according to the following equations 
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 where  obs k 
cat / K m ,  obs k cat , and  obs K m are the observed parameters as 
a function of pH;   i  k 
cat / K m ,   i  k cat , and   i  K m are the parameters for the 
 i th-protonated forms;   i  K 
ua
 are the  i th protonation constants for the 
free enzyme E; and   i  K La are the  i th protonation constant(s) for the 
substrate-bound enzyme ES when it is involved in the cleavage event 
at the rate-limiting step. The global fi tting procedure, simultaneously 
using Eqs. (4a) – (4c) to describe the pH dependence of all three cata-
lytic parameters of Zmp1 (i.e.,  k 
cat / K m ,  k cat , and  K m ), allows to deter-
mine the p K 
a
 of protonating groups, which modulate the enzymatic 
activity of Zmp1. 
 Inhibition assay 
 For inhibition experiments, Zmp1 (10 n m ) was preincubated with 
EDTA, phosphoramidon, and 1,10-phenanthroline (Sigma) in the uni-
versal buffer (see above) at room temperature before addition of the 
synthetic fl uorogenic substrate. Fluorescence was measured after 5 
min of incubation with the fl uorogenic substrate (5  μ m ) at 37 ° C. In the 
case of Ilomastat (British Biotech Pharmaceutical, Cowley, Oxford, 
UK), the inhibition constant  K I was measured obtaining the various 
 K 
m
 from the substrate concentration dependence at various inhibitor 
concentration, using Eqs. (2) and (3) and then plotting data of  K 
m
 as a 
function of inhibitor concentration, as from the following equation 
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 where  K 
m
 is the Michaelis constant at different inhibitor concentra-
tions,  0 K 
m
 is the Michaelis constant in the absence of the inhibitor, [ I ] 
is the inhibitor concentration, and  K I is the inhibition constant. 
 Peptide array 
 Peptide array was performed at JPT Berlin using a commercially 
available microarray (batch 1562, both for peptidase incubation and 
control incubation in triplicates; JPT Peptide Technologies GmbH, 
Berlin, Germany). The library consists of 1989 octameric peptides 
derived from annotated cleavage sites of peptidases or random 
sequences and 1536 pentadecameric random peptide sequences. 
Peptides contain a C-terminal phosphorylated tyrosine for detec-
tion with an antiphosphotyrosine antibody. The peptide microarray 
was incubated with 10  μ g/ml Zmp1 (total reaction volume 400  μ l) 
for 4 h at 37 ° C, using a microarray sandwich-like construction. As 
a control sample, an additional incubation was carried out in the 
absence of the target peptidase, which was followed by washing 
steps with 50 m m TBS buffer, pH 7.2, and ddH 2 O. Subsequent dry-
ing with a microarray centrifuge was performed. Microarrays were 
fi rst incubated with anti-pTyr-antibody (for about 45 min) and then 
for 30 min with Dylight 649-labeled antimouse-antibody. For detec-
tion, a Tecan HS4800 microarray processing station was used. Total 
incubation time was 45 min for anti-pTyr-100-antibody and 30 min 
for antimouse-antibody, followed by washing steps with 50 m m 
TBS, pH 7.2, and SSC buffer, pH 7.0 (JPT). Finally, the microarray 
plates were dried using a nitrogen stream. Analysis was performed 
with high-resolution fl uorescence scanner (Axon Genepix 4200 AL 
Scanner), and Spot-recognition software Genepix 6.0 and Microsoft 
Excel were used for data analysis. A reduction by more than 90 % of 
signal intensity was considered as effective cleavage. 
 Cleavage site determination by MALDI-TOF 
 Peptide cleavage assay was performed as following: 100  μ m neuropep-
tides were incubated with or without Zmp1 (20 n m ) for 5 min at 37 ° C 
in a total volume of 200  μ l. Then, 1  μ l of a 1:100 dilution with MALDI 
Matrix solution (consisting of 60 % acetonitrile, 0.1 % trifl uoroacetic 
acid in ddH 2 O, and 4 mg/ml  α -cyano-4-hydroxy cinnamic acid) was 
spotted on the MALDI plate. After evaporation of solutes, MALDI 
spectra were recorded with a 4800 plus MALDI TOF/TOF Analyzer 
(Applied Biosystems, Foster City, CA, USA). MALDI was equipped 
with a 355-nm Nd:YAG laser that operates at a repetition rate of 200 
Hz. MS spectra were acquired in the refl ectron mode, typically in the 
mass range from 600 Da to 4000 Da. The MS spectra were externally 
calibrated using a standard peptide mixture (Applied Biosystems). 
Recording software was 4000 Series Explorer, and for the fi nal prepa-
ration of the fi gures, Data Explorer, Microsoft Excel, and Prism Graph 
were used. 
 LC-MS of bradykinin sequence 
 Bradykinin-elongated peptide with the sequence H 2 N-
RPPGFSPFRSVTV-NH 2 (C-terminally tagged with an amide group to 
avoid negative charge effects) was synthesized by JPT and dissolved 
in the assay buffer (100 m m Tris, pH 7.3, 100 m m NaCl, 10 m m CaCl 2 ) 
at a fi nal concentration of 1 mg/ml. Zmp1 was added to individual 
vials at concentrations of 10, 40, and 200 n m ; a vial was kept in the 
absence of peptidase as a control. At different time intervals, 8  μ l were 
injected into LC-MS system, and UV traces were recorded with Agilent 
LC-1200 VWD Detector at 220 nm; MS traces were recorded using 
Agilent Single-Quad G6130 mass spectrometer. All evaluations were 
performed with Agilent Chemstation B0301 data analysis software. 
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